Lyme Disease Diagnostics Market 2019 Global Size, Growth, Emerging Technologies, Regional Trends, Sales Revenue, Key Players, Future Plans and Opportunity Assessment by 2027

An insight into Lyme Disease Diagnostics Market

The market report discusses new product launches, new product approvals by regulatory authorities, and products in development. It also discusses novel technologies developed by key players and key ongoing research in the healthcare industry. The market report uses stats regarding various insights that are obtained from reliable sources such as the Centers for Disease Control and Prevention (CDC), American Health Association (AHA), and Food and Drug Administration (FDA). The report also offers complete information about products in the pipeline, tests in trial phases, and product recalls by regulatory authorities.


Description About Lyme Disease Diagnostics Market

Lyme disease occurs due to bacterium Borrelia burgdorferi (Bb) and is transmitted to humans through the bite of infected blacklegged ticks. Its general symptoms include fatigue, headache, fever and a skin rash called erythema migrans. The infection can spread to heart, nervous system and joints if left untreated. Centers for Disease Control and Prevention (CDC) recommends a two-step process to diagnose Lyme infection. The first step uses a testing procedure called enzyme immunoassay (EIA) or, an indirect immunofluorescence assay (IFA).

PDF Brochure Of This Report @

Lyme Disease Diagnostics Market Growth

Lyme disease is a difficult medical condition to identify as it can be confused with increasing cases of tick-borne infectious diseases, emergence of new vector-borne diseases, and the complexity and variations of symptoms in each patient. Rising prevalence of Lyme disease and increasing focus of governments towards improvement of healthcare facilities is expected to drive growth of the Lyme disease diagnostics market during the forecast period.

Major Players Operating In the Lyme Disease Diagnostics Market Include: Abbott Laboratories, Affymetrix Inc., Alere Inc., Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon Life Sciences, Covance Inc., Fresenius Medical Care AG & Co., GlaxoSmithKline Pharmaceuticals Ltd., Roche Diagnostics International Ltd., Siemens AG, and T2 Biosystems, Immunetics Inc.

Impact of COVID-19

Similar to other industries, the healthcare sector has been impacted with the outbreak of COVID-19 across the globe. However, key market players have made necessary changes to adopt to changed circumstances. Lyme Disease Diagnostics has emerged an alternative solution to conventional medical diagnostics, where physicians can offer medical advices from remote places.

Buy Now with Discount for Premium Report @

Frequently Asked Questions

  1. What are the growth estimates for Lyme Disease Diagnostics Market till 2027?

  2. What is the compound annual growth rate (CAGR) of the Lyme Disease Diagnostics Market for next 7 years?

  3. What are the future opportunities in the market?

  4. What are the factors driving the growth of the market?

  5. Which are the most dynamic companies and what are their recent developments within the Lyme Disease Diagnostics Market?

If you have any questions about any of our “Lyme Disease Diagnostics Market report” please do not hesitate to contact us at

Customization Of The Report:

Coherent Market Insights provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Related Articles

Back to top button